It depends on your plan and diagnosis: Most Illinois insurance plans cover GLP-1s for diabetes (Ozempic, Mounjaro.) Coverage for obesity (Wegovy, Zepbound) varies significantly Blue Cross Blue Shield of Illinois: Variable by plan, often requires BMI 30+ and prior weight loss attempts UnitedHealthcare: Many plans exclude obesity medications entirely Aetna: Some plans cover with prior authorization Illinois Medicaid: Covers for diabetes, limited obesity coverage We help with prior authorizations and appeals
Exposure to direct sunlight should also be avoided, as it can affect the chemical composition of the medication
A host of factors need to be considered, including the individuals health status, priorities, comorbidities and other medications, as well as the new drugs cautions and contraindications, side effects, and beneficial effects beyond glucose lowering
After all, semaglutide is semaglutide
The analysis, conducted by researchers from the University of Oxford and supported by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre and the Medical Research Council, revealed that taking the drug, a popular medication for type 2 diabetes and, separately, for obesity, had no increased risk of adverse neurological or psychiatric outcomes compared to other antidiabetic medications, challenging recent concerns about the drug's safety